Skip to main content
. 2021 Mar 31;4(1):101–117. doi: 10.1007/s42247-021-00182-w

Fig. 8.

Fig. 8

Scheme of CaPNPs used for vaccine. Left: CaPNPs functionalized with CpGm adjuvant and two different peptides as antigens. Top right: CaPNPs were able to reduce cell-to-cell virus spread in vitro. Bottom right: CaP nanoparticles were able to immunize mice against HSV-1. Reproduced with permission from ref. [116]. Copyright 2019 Elsevier B.V